Skip header and navigation

13 records – page 1 of 1.

Vivre avec un stimulateur cardiaque (pacemaker)

https://libcat.nshealth.ca/en/permalink/chpams36502
Nova Scotia Health Authority. Heart Health. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1944
Available Online
View Pamphlet
On utilise le stimulateur cardiaque (pacemaker) pour éviter que le cœur batte trop lentement. Il peut aussi être utilisé pour augmenter votre fréquence cardiaque selon l’activité que vous faites. La pile du stimulateur cardiaque dure habituellement entre 7 et 10 ans. Vous aurez besoin d’un nouvel appareil quand la pile deviendra faible. Vous trouverez ci-dessous les précautions à prendre à la maison, de même que les choses à faire en cas de complications. ; This is a French translation of the E…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Heart Health
Alternate Title
Living with your pacemaker
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
French
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Pacemaker, Artificial
Subjects (LCSH)
Cardiac pacemakers
Abstract
On utilise le stimulateur cardiaque (pacemaker) pour éviter que le cœur batte trop lentement. Il peut aussi être utilisé pour augmenter votre fréquence cardiaque selon l’activité que vous faites. La pile du stimulateur cardiaque dure habituellement entre 7 et 10 ans. Vous aurez besoin d’un nouvel appareil quand la pile deviendra faible. Vous trouverez ci-dessous les précautions à prendre à la maison, de même que les choses à faire en cas de complications.
This is a French translation of the English pamphlet 0019, “Living With Your Pacemaker”. A pacemaker is used to prevent the heart from beating too slowly. It can also be used to increase your heart rate to suit your activity. A pacemaker battery will usually last 7-10 years. When the battery runs low, you will need a new device. Precautions that need to be followed at home are outlined. The best actions to take for certain complications are given.
Responsibility
Prepared by: Heart Health
Pamphlet Number
1944
Less detail

Living with your pacemaker

https://libcat.nshealth.ca/en/permalink/chpams34153
Nova Scotia Health Authority. Heart Health. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0019
Available Online
View Pamphlet
A pacemaker is used to prevent your heart from beating too slowly. It can also be used to make your heart beat faster to suit your activity. You will need to have surgery to have the device placed in your body. This pamphlet explains how your heart beats, what happens if you have problems with your heartbeat, what a pacemaker is, how the procedure is done, what will happen after your procedure, and your care at home. A list of symptoms that require you to call 911 is included. The French versi…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Heart Health
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Pacemaker, artificial
Subjects (LCSH)
Cardiac pacemakers
Specialty
Cardiovascular System
Abstract
A pacemaker is used to prevent your heart from beating too slowly. It can also be used to make your heart beat faster to suit your activity. You will need to have surgery to have the device placed in your body. This pamphlet explains how your heart beats, what happens if you have problems with your heartbeat, what a pacemaker is, how the procedure is done, what will happen after your procedure, and your care at home. A list of symptoms that require you to call 911 is included. The French version of this pamphlet 1944, "Vivre avec un stimulateur cardiaque (pacemaker)", is also available.
Responsibility
Prepared by: Heart Health
Pamphlet Number
0019
Less detail

Cardiovascular device implant

https://libcat.nshealth.ca/en/permalink/chpams35554
Nova Scotia Health Authority. QEII. Heart Heatlh Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1576
Available Online
View Pamphlet
This guide will help you learn about your care before and after one of 2 types of cardiovascular device implant procedures, a pacemaker or an ICD (Implantable Cardioverter-defibrillator). Topics include what will happen on the day of the procedure, what to bring to the hospital, instructions for the night before and day of your procedure, skin prep, planning for your discharge, care of your device insertion site, and signs of infection.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Heart Heatlh Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.): digital, PDF file
Subjects (MeSH)
Pacemaker, artificial
Defibrillators, Implantable
Subjects (LCSH)
Cardiac pacemakers
Implantable cardioverter-defibrillators
Specialty
Cardiovascular System
Abstract
This guide will help you learn about your care before and after one of 2 types of cardiovascular device implant procedures, a pacemaker or an ICD (Implantable Cardioverter-defibrillator). Topics include what will happen on the day of the procedure, what to bring to the hospital, instructions for the night before and day of your procedure, skin prep, planning for your discharge, care of your device insertion site, and signs of infection.
Notes
Previous title: Cardiovascular Device Implants
Responsibility
Prepared by: Heart Health Services, QEII
Pamphlet Number
1576
Less detail

Ventricular assist devices (VADs)

https://libcat.nshealth.ca/en/permalink/chpams34893
Nova Scotia Health Authority. Cardiovascular Surgery. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0931
Available Online
View Pamphlet
A VAD acts like the heart’s ventricle by pumping blood throughout the body. This pamphlet describes the types of VADs, what will happen during surgery, risks, and what to expect after. The French version of this pamphlet 1853, "Dispositifs d’assistance ventriculaire (DAV)", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cardiovascular Surgery
Alternate Title
VAD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Heart-Assist Devices
Heart Failure - surgery
Heart, Artificial
Heart Diseases - surgery
Postoperative Care
Subjects (LCSH)
Heart, Artificial
Heart failure
Heart--Surgery
Heart--Diseases--Treatment
Postoperative care
Specialty
Cardiovascular system
Surgery
Abstract
A VAD acts like the heart’s ventricle by pumping blood throughout the body. This pamphlet describes the types of VADs, what will happen during surgery, risks, and what to expect after. The French version of this pamphlet 1853, "Dispositifs d’assistance ventriculaire (DAV)", is also available.
Notes
Previous title: Ventricular assist devices (VAD)
Responsibility
Prepared by: Ventricular Assist Device Coordinator, QE II
Pamphlet Number
0931
Less detail

Dispositifs d’assistance ventriculaire (DAV)

https://libcat.nshealth.ca/en/permalink/chpams35929
Nova Scotia Health Authority. Cardiovascular Surgery. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1853
Available Online
View Pamphlet
Un dispositif d’assistance ventriculaire (DAV) peut être recommandé pour les candidats éventuels à une transplantation cardiaque. Le DAV agit comme un ventricule du cœur en pompant le sang dans l’organisme. La pompe est dotée d’une source d’alimentation externe. La présente brochure décrit les types de DAV, l’implantation d’un DAV, les risques de la chirurgie et ce à quoi s’attendre après l’opération. ; This pamphlet is a French translation of "Ventricular Assist Devices (VAD)" pamphlet 0931. A…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cardiovascular Surgery
Alternate Title
Ventricular assist devices (VAD)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
French
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Heart-Assist Devices
Heart Failure - surgery
Heart, Artificial
Heart Diseases - surgery
Postoperative Care
Subjects (LCSH)
Heart, Artificial
Heart failure
Heart--Surgery
Heart--Diseases--Treatment
Postoperative care
Specialty
Cardiovascular System
Surgery
Abstract
Un dispositif d’assistance ventriculaire (DAV) peut être recommandé pour les candidats éventuels à une transplantation cardiaque. Le DAV agit comme un ventricule du cœur en pompant le sang dans l’organisme. La pompe est dotée d’une source d’alimentation externe. La présente brochure décrit les types de DAV, l’implantation d’un DAV, les risques de la chirurgie et ce à quoi s’attendre après l’opération.
This pamphlet is a French translation of "Ventricular Assist Devices (VAD)" pamphlet 0931. A Ventricular Assist Device (VAD) may be recommended if a person is a potential candidate for heart transplant. The VAD acts like the heart’s ventricle by pumping blood throughout the body. The pump has an external power source. This pamphlet describes the types of VADs, implanting a VAD, risks of surgery, and what to expect after surgery.
Responsibility
Prepared by: Sonya Osmond RN, Ventricular Assist Device Coordinator
Pamphlet Number
1853
Less detail

Dalteparin (Fragmin) to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1760
Available Online
View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Dalteparin
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Blood--coagulation
Specialty
Nephrology
Abstract
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1760
Less detail

Cannabinoids for managing pain

https://libcat.nshealth.ca/en/permalink/chpams35259
Nova Scotia Health Authority. Pain Management Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1350
Available Online
View Pamphlet
Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included. The French version of this pamphlet 1792, "Cannabinoïdes pour le traitement …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pain Management Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cannabinoids
Analgesics
Pain Management
Subjects (LCSH)
Cannabinoids
Analgesics
Pain--Treatment
Specialty
Pain Management
Abstract
Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included. The French version of this pamphlet 1792, "Cannabinoïdes pour le traitement de la douleur", is also available.
Notes
Previous title: Cannabinoid analgesics for pain management
Responsibility
Prepared by: Pain Management Unit
Pamphlet Number
1350
Less detail

Perioperative Blood Management Service (PBMS)

https://libcat.nshealth.ca/en/permalink/chpams35471
Nova Scotia Health Authority. Perioperative Blood Management Service. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1396
Available Online
View Pamphlet
Perioperative blood management helps patients before, during, and after planned surgery. Topics include: benefits, anemia, blood components, normal blood counts, blood transfusions, and informed consent. An FAQ (frequently asked questions) section is included. We have described the preoperative period (before surgery) with these topics: donating your own blood, donating blood for a family member or friend, drugs and products that help you during surgery, procedures performed during surgery, art…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Perioperative Blood Management Service
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Blood Transfusion
Blood Donors
Subjects (LCSH)
Blood--Transfusion
Blood donors
Abstract
Perioperative blood management helps patients before, during, and after planned surgery. Topics include: benefits, anemia, blood components, normal blood counts, blood transfusions, and informed consent. An FAQ (frequently asked questions) section is included. We have described the preoperative period (before surgery) with these topics: donating your own blood, donating blood for a family member or friend, drugs and products that help you during surgery, procedures performed during surgery, artificial blood, and refusing a blood transfusion. A resources section is also provided. The French version of this pamphlet 2082, "Service de gestion du sang périopératoire", is also available.
Responsibility
Prepared by: Perioperative Blood Management Service
Pamphlet Number
1396
Less detail
Nova Scotia Health Authority. QEII. Eye Care Centre. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0582
Available Online
View Pamphlet
Your health care provider has talked with you about why your eye or the contents of your eye must be removed. This pamphlet will help you learn how to safely care for yourself after your procedure. The medical term for eye removal is enucleation. The medical term for removing the contents of the eye and leaving the outer coat (sclera) behind is evisceration. Both procedures mean permanent loss of the eye. This pamphlet explains what will happen before and after your surgery, including wearing a…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Eye Care Centre
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Eye Enucleation
Eye Evisceration
Subjects (LCSH)
Eye--Enucleation
Specialty
Ophthalmology
Abstract
Your health care provider has talked with you about why your eye or the contents of your eye must be removed. This pamphlet will help you learn how to safely care for yourself after your procedure. The medical term for eye removal is enucleation. The medical term for removing the contents of the eye and leaving the outer coat (sclera) behind is evisceration. Both procedures mean permanent loss of the eye. This pamphlet explains what will happen before and after your surgery, including wearing a dressing, medication, care at home, and emotions you may have. Information about having a prosthesis (artificial eye) is given. A list of symptoms that require immediate medical attention is provided.
The French version of this pamphlet 1897, "Ablation de l’oeil", is also available.
Responsibility
Prepared by: Eye Care Centre
Pamphlet Number
0582
Less detail

Cannabinoïdes pour le traitement de la douleur

https://libcat.nshealth.ca/en/permalink/chpams35847
Nova Scotia Health Authority. Pain Management Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1792
Available Online
View Pamphlet
Les cannabinoïdes sont un groupe de médicaments parfois appelés « analgésiques à la marijuana » (antidouleurs) ou « cannabioïdes synthétiques » (artificiels). Ce dépliant explique pourquoi on vous a prescrit un cannabinoïde, la quantité et la façon de prendre ce médicament, les effets secondaires et la manière de rester en sécurité lorsque vous prenez ce médicament. Vous y trouverez également de l'information sur la conservation de ce médicament et sur ce qu'il faut faire en cas d'oubli d'une d…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pain Management Unit
Alternate Title
Cannabinoids for managing pain
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cannabinoids
Analgesics
Pain Management
Subjects (LCSH)
Cannabinoids
Analgesics
Pain--Treatment
Abstract
Les cannabinoïdes sont un groupe de médicaments parfois appelés « analgésiques à la marijuana » (antidouleurs) ou « cannabioïdes synthétiques » (artificiels). Ce dépliant explique pourquoi on vous a prescrit un cannabinoïde, la quantité et la façon de prendre ce médicament, les effets secondaires et la manière de rester en sécurité lorsque vous prenez ce médicament. Vous y trouverez également de l'information sur la conservation de ce médicament et sur ce qu'il faut faire en cas d'oubli d'une dose.
This pamphlet is a French translation of "Cannabinoid Analgesics for Pain Management" pamphlet 1350. Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included.
Responsibility
Prepared by: Pain Management Unit
Pamphlet Number
1792
Less detail

Service de gestion du sang périopératoire

https://libcat.nshealth.ca/en/permalink/chpams36688
Nova Scotia Health Authority. Perioperative Blood Management Service. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2082
Available Online
View Pamphlet
La gestion du sang périopératoire aide les patients avant, pendant et après une opération planifiée. Cette brochure traite des avantages, de l’anémie, des composants sanguins, des numérations globulaires normales, des transfusions sanguines et du consentement éclairé. On y trouve aussi une foire aux questions. Les sujets suivants portent sur la période préopératoire (avant l’opération) : don de sang pour vous-même, don de sang pour un membre de la famille ou un proche, médicaments et produits…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Perioperative Blood Management Service
Alternate Title
Perioperative blood management (PBM) service
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (14 p.) : digital, PDF file
Subjects (MeSH)
Blood Transfusion
Blood Donors
Subjects (LCSH)
Blood--Transfusion
Blood donors
Specialty
Hematology
Abstract
La gestion du sang périopératoire aide les patients avant, pendant et après une opération planifiée. Cette brochure traite des avantages, de l’anémie, des composants sanguins, des numérations globulaires normales, des transfusions sanguines et du consentement éclairé. On y trouve aussi une foire aux questions. Les sujets suivants portent sur la période préopératoire (avant l’opération) : don de sang pour vous-même, don de sang pour un membre de la famille ou un proche, médicaments et produits pouvant vous aider pendant l’opération, interventions effectuées durant l’opération, sang artificiel et refus d’une transfusion sanguine. Une section de la brochure propose des ressources à consulter.
This is a French translation of the English pamphlet 1396, “Perioperative Blood Management (PBM) Service”. Perioperative blood management helps patients before, during, and after planned surgery. Topics include: benefits, anemia, blood components, normal blood counts, blood transfusions, and informed consent. An FAQ (frequently asked questions) section is included. We have described the preoperative period (before surgery) with these topics: donating your own blood, donating blood for a family member or friend, drugs and products that help you during surgery, procedures performed during surgery, artificial blood, and refusing a blood transfusion. A resources section is also provided.
Responsibility
Prepared by: Perioperative Blood Management Service
Pamphlet Number
2082
Less detail

Warfarine sodique

https://libcat.nshealth.ca/en/permalink/chpams36661
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2063
Available Online
View Pamphlet
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également f…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Coumadin
Warfarin sodium
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Abstract
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également fournies sur la façon de prendre le médicament, les doses manquées, les analyses sanguines RIN (ou INR), les interactions médicamenteuses et alimentaires, les effets secondaires et les mesures de sécurité. Vous y trouverez aussi des numéros où appeler si vous avez des questions.
This is a French translation of the English pamphlet 0373 “Warfarin Sodium". This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions.
Responsibility
Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
Pamphlet Number
2063
Less detail

Ablation de l’oeil

https://libcat.nshealth.ca/en/permalink/chpams36457
Nova Scotia Health Authority. QEII. Eye Care Centre. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1897
Available Online
View Pamphlet
Vous et votre médecin avez parlé des raisons pour lesquelles il est nécessaire d’enlever votre œil ou le contenu du globe oculaire. Ce dépliant explique comment prendre soin de vous en toute sécurité. L’énucléation est le terme médical qui désigne le retrait ou l’ablation de l’œil. Le terme médical utilisé pour parler du retrait du contenu du globe oculaire en conservant la couche externe (coque sclérale ou sclère) est éviscération. Les deux interventions entraînent la perte permanente de l’œil…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Eye Care Centre
Alternate Title
Eye removal
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Eye Enucleation
Eye Evisceration
Subjects (LCSH)
Eye--Enucleation
Specialty
Ophthalmology
Abstract
Vous et votre médecin avez parlé des raisons pour lesquelles il est nécessaire d’enlever votre œil ou le contenu du globe oculaire. Ce dépliant explique comment prendre soin de vous en toute sécurité. L’énucléation est le terme médical qui désigne le retrait ou l’ablation de l’œil. Le terme médical utilisé pour parler du retrait du contenu du globe oculaire en conservant la couche externe (coque sclérale ou sclère) est éviscération. Les deux interventions entraînent la perte permanente de l’œil. Ce dépliant explique ce qui se passe avant et après la chirurgie, le port d’une chemise d’hôpital, les médicaments, les soins à la maison ainsi que vos émotions. Vous y trouverez de plus des informations sur les prothèses oculaires (œil artificiel) ainsi qu’une liste des symptômes nécessitant une consultation médicale immédiate.
This pamphlet is a French translation of "Eye Removal" pamphlet 0582. Your health care provider has talked with you about why your eye or the contents of your eye must be removed. This pamphlet will help you learn how to safely care for yourself after your procedure. The medical term for eye removal is enucleation. The medical term for removing the contents of the eye and leaving the outer coat (sclera) behind is evisceration. Both procedures mean permanent loss of the eye. This pamphlet explains what will happen before and after your surgery, including wearing a dressing, medication, care at home, and emotions you may have. Information about having a prosthesis (artificial eye) is given. A list of symptoms that require immediate medical attention is provided.
Responsibility
Prepared by: Eye Care Centre
Pamphlet Number
1897
Less detail

13 records – page 1 of 1.